Next Article in Journal
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation
Next Article in Special Issue
A Comparative Study Between Copy Number Alterations and PRAME Immunohistochemical Pilot Study in Challenging Melanocytic Lesions
Previous Article in Journal
Unveiling the Complexity of KMT2A Rearrangements in Acute Myeloid Leukemias with Optical Genome Mapping
 
 
Article

Article Versions Notes

Cancers 2024, 16(24), 4172; https://doi.org/10.3390/cancers16244172
Action Date Notes Link
article xml file uploaded 14 December 2024 11:14 CET Original file -
article xml uploaded. 14 December 2024 11:14 CET Update https://www.mdpi.com/2072-6694/16/24/4172/xml
article pdf uploaded. 14 December 2024 11:14 CET Version of Record https://www.mdpi.com/2072-6694/16/24/4172/pdf
article supplementary file uploaded. 14 December 2024 11:14 CET - https://www.mdpi.com/2072-6694/16/24/4172#supplementary
article html file updated 14 December 2024 11:16 CET Original file https://www.mdpi.com/2072-6694/16/24/4172/html
Back to TopTop